Loading
Latest filing published 10 Aug 2023 for DA32 Life Science Tech Acquisition Corp..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
ARCH Venture Fund XI, L.P. appears in our data through filings on DA32 Life Science Tech Acquisition Corp. shares, published by SEC (Form 4). Over a trading history stretching from 30 July 2021 to 28 July 2023, the count stands at 3 filings.
Every open-market trade on record is a purchase: 1 purchase worth €13.5M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 10 August 2023 came the latest disclosure, a transaction in DA32 Life Science Tech Acquisition Corp. The clock since the last published purchase (3 August 2021) now reads 1,908 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Same trade as the filing by Deerfield Management Company, L.P. (Series C), counted once
2 of 1 declaration